CA3137442A1 - Disinfecting composition and related methods - Google Patents
Disinfecting composition and related methodsInfo
- Publication number
- CA3137442A1 CA3137442A1 CA3137442A CA3137442A CA3137442A1 CA 3137442 A1 CA3137442 A1 CA 3137442A1 CA 3137442 A CA3137442 A CA 3137442A CA 3137442 A CA3137442 A CA 3137442A CA 3137442 A1 CA3137442 A1 CA 3137442A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- hydrogen peroxide
- saponin
- weight
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000000249 desinfective effect Effects 0.000 title description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 132
- 229930182490 saponin Natural products 0.000 claims abstract description 53
- 150000007949 saponins Chemical class 0.000 claims abstract description 53
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000645 desinfectant Substances 0.000 claims abstract description 17
- 239000003381 stabilizer Substances 0.000 claims abstract description 15
- 229910052751 metal Inorganic materials 0.000 claims abstract description 14
- 239000002184 metal Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000002738 chelating agent Substances 0.000 claims abstract description 9
- 238000011012 sanitization Methods 0.000 claims abstract description 7
- 235000017709 saponins Nutrition 0.000 claims description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 9
- 241000526900 Camellia oleifera Species 0.000 claims description 8
- 235000001014 amino acid Nutrition 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 241000580955 Sapindus mukorossi Species 0.000 claims description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 241001454523 Quillaja saponaria Species 0.000 claims description 6
- 235000009001 Quillaja saponaria Nutrition 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 6
- 239000000123 paper Substances 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 5
- 240000003946 Saponaria officinalis Species 0.000 claims description 5
- 239000003125 aqueous solvent Substances 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 4
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- 229940045872 sodium percarbonate Drugs 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 241000588626 Acinetobacter baumannii Species 0.000 claims description 3
- 241001678559 COVID-19 virus Species 0.000 claims description 3
- 241000222122 Candida albicans Species 0.000 claims description 3
- 241000711573 Coronaviridae Species 0.000 claims description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- 241000606768 Haemophilus influenzae Species 0.000 claims description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 241000315672 SARS coronavirus Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 240000000111 Saccharum officinarum Species 0.000 claims description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 3
- 241000580938 Sapindus Species 0.000 claims description 3
- 240000003377 Shepherdia canadensis Species 0.000 claims description 3
- 235000018324 Shepherdia canadensis Nutrition 0.000 claims description 3
- 206010041925 Staphylococcal infections Diseases 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 235000006468 Thea sinensis Nutrition 0.000 claims description 3
- 229940095731 candida albicans Drugs 0.000 claims description 3
- BHDAXLOEFWJKTL-UHFFFAOYSA-L dipotassium;carboxylatooxy carbonate Chemical compound [K+].[K+].[O-]C(=O)OOC([O-])=O BHDAXLOEFWJKTL-UHFFFAOYSA-L 0.000 claims description 3
- 229940023064 escherichia coli Drugs 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 229940047650 haemophilus influenzae Drugs 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 229940045505 klebsiella pneumoniae Drugs 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 claims description 3
- 244000052769 pathogen Species 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 229960001922 sodium perborate Drugs 0.000 claims description 3
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 claims description 3
- 239000004753 textile Substances 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 38
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 24
- 239000000463 material Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- -1 propyl alcohols Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000029918 bioluminescence Effects 0.000 description 4
- 238000005415 bioluminescence Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002070 germicidal effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002338 glycosides Chemical group 0.000 description 2
- 239000010438 granite Substances 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000003641 microbiacidal effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical class OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
- 241000219287 Saponaria Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003406 mycobactericidal effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002760 rocket fuel Substances 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003330 sporicidal effect Effects 0.000 description 1
- 239000002422 sporicide Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
- A61L2/186—Peroxide solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/662—Carbohydrates or derivatives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0047—Detergents in the form of bars or tablets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/06—Powder; Flakes; Free-flowing mixtures; Sheets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3942—Inorganic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3947—Liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/15—Biocide distribution means, e.g. nozzles, pumps, manifolds, fans, baffles, sprayers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Described herein is a disinfectant composition comprising a hydrogen peroxide source and a saponin source. An optional stabilizer, such as a metal chelator, and/or a solvent, such as water, may also be included in the compositions described herein. Also described are hand sanitizers and methods for sanitizing surfaces using the composition described herein.
Description
DISINFECTING COMPOSITION AND RELATED METHODS
Field The present invention relates to disinfecting compositions. More specifically, the present invention is, in aspects, concerned with disinfecting compositions, sprays, sanitizers, and related methods of making and using same.
Background Prevention of the spread of viral and bacterial infections through contaminated skin and other surfaces has become an essential part of the fight against pandemic outbreaks. During pandemic outbreaks, healthcare facilities and personnel are exposed to infectious viruses and bacteria beyond their capacity and require extensive and frequent disinfection. Gyms, office buildings, restaurants, and grocery stores will also require more frequent handwashing and sanitization.
During the coronavirus disease 2019 ("COVID-19") pandemic, the strain on healthcare personnel became a critical issue and the need for frequent handwashing shifted from an essential part of the solution to a problem of its own as most existing handwashing products have their own safety shortcomings.
A problem with most of existing handwashing products is the trade-off between disinfection efficacy and skin tolerance. For example, alcohol-based sanitizers are required to contain more than 60% alcohol, and usually up to about 76%, to be considered effective disinfectants, and despite containing other components to control the detrimental effects of the high concentration of alcohol on the skin, the high-concentration level of alcohol can be abrasive on the skin. Frequent skin contacts with these alcoholic sanitizers have highlighted the need for less aggressive yet effective sanitizers.
Another concern with alcohol-based sanitizers arising from the high concentration of alcohol is their flammability. Ethyl and propyl alcohols are highly flammable at high concentrations with the flash point of a typical 63% ethanol-based sanitizers being approximately 70 degrees Fahrenheit or 21 degrees Celsius. This will make the stockpiling of these products a considerable hazard even though maintaining a high inventory level of disinfectants during a pandemic outbreak is vital.
Additionally, the widespread application of alcohol-based disinfectants is raising a reasonable concern about the release of Volatile Organic Compounds ("VOCs") as their consumption has increased to billions of liters per year.
Attempts have been made in the past to overcome the shortcomings of currently used sanitizers through the incorporation of additives, as in US Patent No.
US6617294B2.
Date recue / Date received 2021-11-02
Field The present invention relates to disinfecting compositions. More specifically, the present invention is, in aspects, concerned with disinfecting compositions, sprays, sanitizers, and related methods of making and using same.
Background Prevention of the spread of viral and bacterial infections through contaminated skin and other surfaces has become an essential part of the fight against pandemic outbreaks. During pandemic outbreaks, healthcare facilities and personnel are exposed to infectious viruses and bacteria beyond their capacity and require extensive and frequent disinfection. Gyms, office buildings, restaurants, and grocery stores will also require more frequent handwashing and sanitization.
During the coronavirus disease 2019 ("COVID-19") pandemic, the strain on healthcare personnel became a critical issue and the need for frequent handwashing shifted from an essential part of the solution to a problem of its own as most existing handwashing products have their own safety shortcomings.
A problem with most of existing handwashing products is the trade-off between disinfection efficacy and skin tolerance. For example, alcohol-based sanitizers are required to contain more than 60% alcohol, and usually up to about 76%, to be considered effective disinfectants, and despite containing other components to control the detrimental effects of the high concentration of alcohol on the skin, the high-concentration level of alcohol can be abrasive on the skin. Frequent skin contacts with these alcoholic sanitizers have highlighted the need for less aggressive yet effective sanitizers.
Another concern with alcohol-based sanitizers arising from the high concentration of alcohol is their flammability. Ethyl and propyl alcohols are highly flammable at high concentrations with the flash point of a typical 63% ethanol-based sanitizers being approximately 70 degrees Fahrenheit or 21 degrees Celsius. This will make the stockpiling of these products a considerable hazard even though maintaining a high inventory level of disinfectants during a pandemic outbreak is vital.
Additionally, the widespread application of alcohol-based disinfectants is raising a reasonable concern about the release of Volatile Organic Compounds ("VOCs") as their consumption has increased to billions of liters per year.
Attempts have been made in the past to overcome the shortcomings of currently used sanitizers through the incorporation of additives, as in US Patent No.
US6617294B2.
Date recue / Date received 2021-11-02
2 Another concern is about the fact that there are very few effective and safe chemical sporicides, particularly in cold soaking instruments sensitive to chemical attack. The most widely used sporicidal solutions are based on aldehydes, short chain alcohols, phenolic compounds and certain peroxgens. Aldehydes (for example, formaldehyde or glutaraldehyde), although highly effective, suffer from serious occupational safety and environmental elimination risks. Of the peroxgens, the peracids are the most widely used in liquid form. Peracetic and performic acids have been marketed for the disinfection of semi-critical and critical instruments; however, their aggressive chemical nature tends to damage surfaces and instruments with prolonged use.
Alcoholic or phenolic compounds that show good efficacy against mycobacterial species are typically not effective in destroying bacterial endospores.
Mycobactericidal products based on short chain alcohols typically contain these ingredients at high concentrations (usually more than 20% w/w). This makes the products very flammable and toxic. In addition, they are often characterized by a strong alcoholic odor and are therefore difficult to use in large quantities in small enclosed spaces by chemically sensitive individuals. Phenolic compounds can be used by themselves or in combination with other active germicides (such as with quaternary ammonium compounds and solvents), to achieve broad spectrum efficacy. These compounds are also very volatile and show strong unpleasant odors.
In another attempt, US6927237 discloses antimicrobial compositions comprising microbicidal solvents, such as benzyl alcohol, diluent solvents, such as water and additional microbicides. Specific examples disclose compositions comprising benzyl alcohol, water, mixtures of peracids and anionic surfactants.
Solutions of hypochlorite and other chlorine-based compounds are effective against both mycobacteria and bacterial endospores; however, they are easily inactivated by the presence of organic matter, are unstable when diluted, have a strong unpleasant smell of chlorine and are very corrosive and therefore, damage most instruments and surfaces.
Aqueous chemical disinfectants are used in applications where, due to work, environmental or toxicological problems, solvent-based solutions cannot be used. While there are a large number of sanitizing and sanitizing solutions available in the market, there is still a need for an aqueous disinfectant of low volatility, low toxicity, non-corrosive, non-irritating and stable that is effective against hydrophilic viruses, acid-resistant bacteria and bacterial endospores.
Summary In accordance with an aspect, there is provided a disinfectant composition comprising a hydrogen peroxide source and a saponin source.
Date recue / Date received 2021-11-02
Alcoholic or phenolic compounds that show good efficacy against mycobacterial species are typically not effective in destroying bacterial endospores.
Mycobactericidal products based on short chain alcohols typically contain these ingredients at high concentrations (usually more than 20% w/w). This makes the products very flammable and toxic. In addition, they are often characterized by a strong alcoholic odor and are therefore difficult to use in large quantities in small enclosed spaces by chemically sensitive individuals. Phenolic compounds can be used by themselves or in combination with other active germicides (such as with quaternary ammonium compounds and solvents), to achieve broad spectrum efficacy. These compounds are also very volatile and show strong unpleasant odors.
In another attempt, US6927237 discloses antimicrobial compositions comprising microbicidal solvents, such as benzyl alcohol, diluent solvents, such as water and additional microbicides. Specific examples disclose compositions comprising benzyl alcohol, water, mixtures of peracids and anionic surfactants.
Solutions of hypochlorite and other chlorine-based compounds are effective against both mycobacteria and bacterial endospores; however, they are easily inactivated by the presence of organic matter, are unstable when diluted, have a strong unpleasant smell of chlorine and are very corrosive and therefore, damage most instruments and surfaces.
Aqueous chemical disinfectants are used in applications where, due to work, environmental or toxicological problems, solvent-based solutions cannot be used. While there are a large number of sanitizing and sanitizing solutions available in the market, there is still a need for an aqueous disinfectant of low volatility, low toxicity, non-corrosive, non-irritating and stable that is effective against hydrophilic viruses, acid-resistant bacteria and bacterial endospores.
Summary In accordance with an aspect, there is provided a disinfectant composition comprising a hydrogen peroxide source and a saponin source.
Date recue / Date received 2021-11-02
3 In an aspect, the hydrogen peroxide source comprises hydrogen peroxide, sodium percarbonate, potassium percarbonate, sodium perborate, potassium perborate, hydrogen peroxide urea, hydrated forms thereof, or mixtures thereof.
In an aspect, the saponin source comprises a plant extract.
In an aspect, the plant extract comprises an extract of Camellia sinensis, soapwort (Saponaria officinalis), soapberry (Sapindus species), soapbark (Quillaja saponaria), Camellia oleifera, Sapindus mukorossi, sugar beet root saponins, or a mixture thereof.
In an aspect, the saponin is extracted from a nutshell of Sapindus mukorossi.
In an aspect, the saponin is extracted from the defatted seed meal of Camellia oleifera.
In an aspect, the saponin source is Yocca saponin powder.
In an aspect, the composition comprises from about 0.05% to about 8% by weight of the hydrogen peroxide source, such as from about 1% to about 8% by weight for a concentrated composition and from about 0.05% to about 5% by weight for a ready-to-use composition.
In an aspect, the composition comprises from about 0.01% to about 99% by weight of the saponin source, such as from about 1% to about 10% by weight for a concentrated composition and from about 0.05% to about 3% by weight for a ready-to-use composition.
In an aspect, the composition further comprises a solvent.
In an aspect, the solvent comprises an aqueous solvent.
In an aspect, the aqueous solvent comprises distilled water.
In an aspect, the solvent comprises a water-miscible organic solvent.
In an aspect, the water-miscible organic solvent comprises ethanol, propanol, and/or butanol.
In an aspect, the water-miscible organic solvent is present in an amount of from about 0.1% to about 30% by weight of water present in a ready-to-use composition.
In an aspect, the composition further comprises a stabilizer.
In an aspect, the stabilizer comprises a metal chelator.
In an aspect, the metal chelator comprises an amino acid and/or a carboxylic acid.
In an aspect, the amino acid comprises glutamic acid, histidine, glycine and/or lysine and wherein the carboxylic acid comprises acetic acid, gluconic acid, and/or citric acid.
In an aspect, the stabilizer comprises glutamic acid and citric acid.
In an aspect, the stabilizer is present in an amount of from about 0.05% to about 5% by weight such as from about 0.1% to about 5% by weight for a concentrated composition and from about 0.05% to about 1% by weight for a ready-to-use composition.
In an aspect, the composition is free of surfactants other than the saponin source.
In an aspect, the composition is free of synthetic surfactants.
Date recue / Date received 2021-11-02
In an aspect, the saponin source comprises a plant extract.
In an aspect, the plant extract comprises an extract of Camellia sinensis, soapwort (Saponaria officinalis), soapberry (Sapindus species), soapbark (Quillaja saponaria), Camellia oleifera, Sapindus mukorossi, sugar beet root saponins, or a mixture thereof.
In an aspect, the saponin is extracted from a nutshell of Sapindus mukorossi.
In an aspect, the saponin is extracted from the defatted seed meal of Camellia oleifera.
In an aspect, the saponin source is Yocca saponin powder.
In an aspect, the composition comprises from about 0.05% to about 8% by weight of the hydrogen peroxide source, such as from about 1% to about 8% by weight for a concentrated composition and from about 0.05% to about 5% by weight for a ready-to-use composition.
In an aspect, the composition comprises from about 0.01% to about 99% by weight of the saponin source, such as from about 1% to about 10% by weight for a concentrated composition and from about 0.05% to about 3% by weight for a ready-to-use composition.
In an aspect, the composition further comprises a solvent.
In an aspect, the solvent comprises an aqueous solvent.
In an aspect, the aqueous solvent comprises distilled water.
In an aspect, the solvent comprises a water-miscible organic solvent.
In an aspect, the water-miscible organic solvent comprises ethanol, propanol, and/or butanol.
In an aspect, the water-miscible organic solvent is present in an amount of from about 0.1% to about 30% by weight of water present in a ready-to-use composition.
In an aspect, the composition further comprises a stabilizer.
In an aspect, the stabilizer comprises a metal chelator.
In an aspect, the metal chelator comprises an amino acid and/or a carboxylic acid.
In an aspect, the amino acid comprises glutamic acid, histidine, glycine and/or lysine and wherein the carboxylic acid comprises acetic acid, gluconic acid, and/or citric acid.
In an aspect, the stabilizer comprises glutamic acid and citric acid.
In an aspect, the stabilizer is present in an amount of from about 0.05% to about 5% by weight such as from about 0.1% to about 5% by weight for a concentrated composition and from about 0.05% to about 1% by weight for a ready-to-use composition.
In an aspect, the composition is free of surfactants other than the saponin source.
In an aspect, the composition is free of synthetic surfactants.
Date recue / Date received 2021-11-02
4 In an aspect, the composition has a pH of from about 3 to about 6, such as from about 4 to about 5.
In an aspect, the composition is a concentrate.
In an aspect, the concentrate is in the form of a powder or tablet.
In an aspect, the composition is ready-to-use.
In an aspect, the composition disinfects a surface more quickly than a matched composition without a saponin source and/or stabilizer.
In an aspect, the composition is effective against bacteria, viruses, fungi, yeast, or combinations thereof.
In an aspect, the composition is effective against pathogens such as MRSA, E.
coil, coronaviruses such as SARS-CoV-1, SARS-CoV-2, and MERS-CoV; influenza viruses such as H1N1, H5N1; Acinetobacter baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Candida albicans, or combinations thereof.
In accordance with an aspect, there is provided a hand sanitizer comprising the composition described herein.
In accordance with an aspect, there is provided a spray comprising the described herein.
In accordance with an aspect, there is provided a powder or tablet comprising the composition described herein.
In accordance with an aspect, there is provided a method of sanitizing a surface, the method comprising applying the composition described herein.
In an aspect, the surface comprises skin, furniture, medical equipment, fabric, textiles, paper, kitchen surfaces, or combinations thereof.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from said detailed description.
Detailed Description Described herein is a hydrogen peroxide-based disinfectant either in the form of a concentrate or a ready-to-use disinfectant solution. In typical aspects, the compositions and methods described herein avoid the use of synthetic-based surfactants typically found in accelerated hydrogen peroxide formulations. While the replacement of synthetic-based surfactants with natural-based surfactants is an attempt to address one major public concern about the ever-increasing usage of synthetic surfactants, it is also a leap forward in the efficacy Date recue / Date received 2021-11-02
In an aspect, the composition is a concentrate.
In an aspect, the concentrate is in the form of a powder or tablet.
In an aspect, the composition is ready-to-use.
In an aspect, the composition disinfects a surface more quickly than a matched composition without a saponin source and/or stabilizer.
In an aspect, the composition is effective against bacteria, viruses, fungi, yeast, or combinations thereof.
In an aspect, the composition is effective against pathogens such as MRSA, E.
coil, coronaviruses such as SARS-CoV-1, SARS-CoV-2, and MERS-CoV; influenza viruses such as H1N1, H5N1; Acinetobacter baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Candida albicans, or combinations thereof.
In accordance with an aspect, there is provided a hand sanitizer comprising the composition described herein.
In accordance with an aspect, there is provided a spray comprising the described herein.
In accordance with an aspect, there is provided a powder or tablet comprising the composition described herein.
In accordance with an aspect, there is provided a method of sanitizing a surface, the method comprising applying the composition described herein.
In an aspect, the surface comprises skin, furniture, medical equipment, fabric, textiles, paper, kitchen surfaces, or combinations thereof.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from said detailed description.
Detailed Description Described herein is a hydrogen peroxide-based disinfectant either in the form of a concentrate or a ready-to-use disinfectant solution. In typical aspects, the compositions and methods described herein avoid the use of synthetic-based surfactants typically found in accelerated hydrogen peroxide formulations. While the replacement of synthetic-based surfactants with natural-based surfactants is an attempt to address one major public concern about the ever-increasing usage of synthetic surfactants, it is also a leap forward in the efficacy Date recue / Date received 2021-11-02
5 of hydrogen peroxide-based disinfectants, which allows for a broader application of this VOC-free disinfectant.
Definitions In understanding the scope of the present application, the articles "a", "an", "the", and "said" are intended to mean that there are one or more of the elements.
Additionally, the term "comprising" and its derivatives, as used herein, are intended to be open ended terms that specify the presence of the stated features, elements, components, groups, integers, and/or steps, but do not exclude the presence of other unstated features, elements, components, groups, integers and/or steps. The foregoing also applies to words having similar meanings such as the terms, "including", "having" and their derivatives.
It will be understood that any aspects described as "comprising" certain components may also "consist of" or "consist essentially of," (or vice versa) wherein "consisting of' has a closed-ended or restrictive meaning and "consisting essentially of" means including the components specified but excluding other components except for materials present as impurities, unavoidable materials present as a result of processes used to provide the components, and components added for a purpose other than achieving the technical effects described herein. For example, a composition defined using the phrase "consisting essentially of' encompasses any known pharmaceutically acceptable additive, excipient, diluent, carrier, and the like. Typically, a composition consisting essentially of a set of components will comprise less than 5% by weight, typically less than 3% by weight, more typically less than 1% by weight of non-specified components.
It will be understood that any component defined herein as being included may be explicitly excluded by way of proviso or negative limitation, such as any specific compounds or method steps, whether implicitly or explicitly defined herein.
In addition, all ranges given herein include the end of the ranges and also any intermediate range points, whether explicitly stated or not.
Finally, terms of degree such as "substantially", "about" and "approximately"
as used herein mean a reasonable amount of deviation of the modified term such that the end result is not significantly changed. These terms of degree should be construed as including a deviation of at least 5% of the modified term if this deviation would not negate the meaning of the word it modifies.
Compositions Hydrogen peroxide is an oxidizing biocide that releases active oxygen upon contact with viruses and bacteria. Due to the release of this oxidizing active oxygen, hydrogen peroxide is a potent Date recue / Date received 2021-11-02
Definitions In understanding the scope of the present application, the articles "a", "an", "the", and "said" are intended to mean that there are one or more of the elements.
Additionally, the term "comprising" and its derivatives, as used herein, are intended to be open ended terms that specify the presence of the stated features, elements, components, groups, integers, and/or steps, but do not exclude the presence of other unstated features, elements, components, groups, integers and/or steps. The foregoing also applies to words having similar meanings such as the terms, "including", "having" and their derivatives.
It will be understood that any aspects described as "comprising" certain components may also "consist of" or "consist essentially of," (or vice versa) wherein "consisting of' has a closed-ended or restrictive meaning and "consisting essentially of" means including the components specified but excluding other components except for materials present as impurities, unavoidable materials present as a result of processes used to provide the components, and components added for a purpose other than achieving the technical effects described herein. For example, a composition defined using the phrase "consisting essentially of' encompasses any known pharmaceutically acceptable additive, excipient, diluent, carrier, and the like. Typically, a composition consisting essentially of a set of components will comprise less than 5% by weight, typically less than 3% by weight, more typically less than 1% by weight of non-specified components.
It will be understood that any component defined herein as being included may be explicitly excluded by way of proviso or negative limitation, such as any specific compounds or method steps, whether implicitly or explicitly defined herein.
In addition, all ranges given herein include the end of the ranges and also any intermediate range points, whether explicitly stated or not.
Finally, terms of degree such as "substantially", "about" and "approximately"
as used herein mean a reasonable amount of deviation of the modified term such that the end result is not significantly changed. These terms of degree should be construed as including a deviation of at least 5% of the modified term if this deviation would not negate the meaning of the word it modifies.
Compositions Hydrogen peroxide is an oxidizing biocide that releases active oxygen upon contact with viruses and bacteria. Due to the release of this oxidizing active oxygen, hydrogen peroxide is a potent Date recue / Date received 2021-11-02
6 broad-spectrum germicide and a relatively safe one in terms of the long-term effects of the decomposition of hydrogen peroxide-based products on the environment.
While pure and concentrated solutions of hydrogen peroxide are potent and broad-spectrum germicides, they are also dangerous, unstable, and difficult to handle products. For instance, 90% hydrogen peroxide is more dangerous in terms of handling than 90% alcohol. It is one of the most efficient oxidizers in existence and is used for that property in the rocket fuel industry. Hydrogen peroxide solutions stronger than 8% are regulated in terms of shipping and handling and therefore most hydrogen peroxide-based sanitizers are solutions of less than 8%
hydrogen peroxide diluted in water.
Dilute solutions of hydrogen peroxide with hydrogen peroxide content of less than 3%
suffer from their own shortcomings. Most notably, loss of activity over time and relatively lower disinfection efficacy.
An example of the lower disinfection efficacy of hydrogen peroxide is that a 6 weight percent hydrogen peroxide solution, within 5 minutes of contact time, will only exhibit, approximately a 3 Log (i.e., 1,000-fold) reduction against Staphylococcus Aureus, and less than a 2 Log (i.e., 100-fold) reduction against Pseudomonas Aeruginosa. Likewise, a 6,000 parts per million ("ppm") (i.e., 0.6 wt. %) hydrogen peroxide solution, within a 5-minute contact time, will only exhibit about a 1 Log (i.e., 10-fold) reduction against Staphylococcus Aureus, and less than a 1 Log reduction against Pseudomonas Aeruginosa.
The disinfection efficacy of hydrogen peroxide can be improved by using more concentrated hydrogen peroxide or a longer contact time. Stronger solutions with hydrogen peroxide content of higher than 3% and lower than 8% remain unstable and at a concentration higher than 7.5 wt. % are considered corrosive to certain metals that are extensively used in the healthcare industry. As a result, special handling procedures are required for such concentrations. Additionally, contact times longer than 5 minutes are generally not acceptable for most disinfectant applications.
Because of these difficulties in increasing disinfection efficacy, efforts have been made on developing activated or accelerated hydrogen peroxide formulations to improve the efficacy and killing rate of hydrogen peroxide without having to resort to high hydrogen peroxide concentrations and contact times greater than 5 minutes. The development of these activated or accelerated hydrogen peroxide formulations is especially important to industries such as the food, healthcare, hospitality, and even household use.
One attempt to enhance the efficacy of hydrogen peroxide disinfecting solutions is found in U.S. Patent No 5,523,012 to Winterton et al. Winterton discloses that the addition of anionic sulfosuccinate surfactants to an aqueous, hydrogen peroxide solution improved the killing time Date recue / Date received 2021-11-02
While pure and concentrated solutions of hydrogen peroxide are potent and broad-spectrum germicides, they are also dangerous, unstable, and difficult to handle products. For instance, 90% hydrogen peroxide is more dangerous in terms of handling than 90% alcohol. It is one of the most efficient oxidizers in existence and is used for that property in the rocket fuel industry. Hydrogen peroxide solutions stronger than 8% are regulated in terms of shipping and handling and therefore most hydrogen peroxide-based sanitizers are solutions of less than 8%
hydrogen peroxide diluted in water.
Dilute solutions of hydrogen peroxide with hydrogen peroxide content of less than 3%
suffer from their own shortcomings. Most notably, loss of activity over time and relatively lower disinfection efficacy.
An example of the lower disinfection efficacy of hydrogen peroxide is that a 6 weight percent hydrogen peroxide solution, within 5 minutes of contact time, will only exhibit, approximately a 3 Log (i.e., 1,000-fold) reduction against Staphylococcus Aureus, and less than a 2 Log (i.e., 100-fold) reduction against Pseudomonas Aeruginosa. Likewise, a 6,000 parts per million ("ppm") (i.e., 0.6 wt. %) hydrogen peroxide solution, within a 5-minute contact time, will only exhibit about a 1 Log (i.e., 10-fold) reduction against Staphylococcus Aureus, and less than a 1 Log reduction against Pseudomonas Aeruginosa.
The disinfection efficacy of hydrogen peroxide can be improved by using more concentrated hydrogen peroxide or a longer contact time. Stronger solutions with hydrogen peroxide content of higher than 3% and lower than 8% remain unstable and at a concentration higher than 7.5 wt. % are considered corrosive to certain metals that are extensively used in the healthcare industry. As a result, special handling procedures are required for such concentrations. Additionally, contact times longer than 5 minutes are generally not acceptable for most disinfectant applications.
Because of these difficulties in increasing disinfection efficacy, efforts have been made on developing activated or accelerated hydrogen peroxide formulations to improve the efficacy and killing rate of hydrogen peroxide without having to resort to high hydrogen peroxide concentrations and contact times greater than 5 minutes. The development of these activated or accelerated hydrogen peroxide formulations is especially important to industries such as the food, healthcare, hospitality, and even household use.
One attempt to enhance the efficacy of hydrogen peroxide disinfecting solutions is found in U.S. Patent No 5,523,012 to Winterton et al. Winterton discloses that the addition of anionic sulfosuccinate surfactants to an aqueous, hydrogen peroxide solution improved the killing time Date recue / Date received 2021-11-02
7 against Aspergillus fumigatus by lowering it to 7.1 minutes. However, the improvement in killing time remains far too low for most disinfectant applications.
Another attempt to enhance the efficacy of hydrogen peroxide disinfecting solutions is found in U.S. Patent No. 5264229 to Mannig et al. Mannig discloses a process for reducing the overall bacterial count and increasing the shelf life of the aqueous hydrogen peroxide solution by adding sulfo-based surfactants, such as, alkylaryl sulfonates, sulfates, sulfonates of oils and fatty acid, sulfate of alcohols and sulfosuccinates.
In U.S. Patent No. 7658953, a biocidal hydrogen peroxide composition is enhanced by the addition of a surfactant with the structure: R-0-(CH(Y)-CH2-0)n-CH2-COOH, wherein R is C6 to C12 alkyl, Y is H or CH3, and n is 3- 10. The addition of the surfactant was reported to achieve a Log 6 reduction of bacteria in a bacteria suspension within 1-minute following contact with the composition.
Several other patents and patent publications disclose the addition of anionic surfactants based on sulfonic acid to increase the kill rate of an aqueous hydrogen peroxide disinfecting solution: U.S. Patent No. 7354604, U.S. Publication Nos.: 2010/0330196, 2011/0262557, 2011/0129435, 2011/0182958, 2012/0230869, 2012/0177746, 2012/0164237, and European Publication No.: 2338343. The anionic surfactant is chosen from C8 to C16 alkyl aryl sulfonic acids, sulfonated C12 to C22 carboxylic acids, Ce to C22 alkyl diphenyl oxide sulfonic acids, C8 to C22 alkyl sulfonic acids, and Ce to C18 alkyl or alkenyl esters of sulfosuccinic acids.
However, the use of anionic sulfonic acid-based surfactants is less desirable in applications where disinfection, and not cleaning, is the primary function to be achieved.
Furthermore, hydrogen peroxide solutions suffer from loss of activity over time. As the physical chemistry of hydrogen peroxide suggests, and is confirmed through practical monitoring, hydrogen peroxide solutions tend to dissociate and release oxygen over time, converting to water and nascent active oxygen. High-strength hydrogen peroxide solutions can go through this dissociation process rapidly and, occasionally, violently. Low-strength hydrogen peroxide solutions dissociate more slowly but, nevertheless, lose their activity over a long storage period. The mechanisms through which this dissociation happens are categorized as metal catalyzed reactions, in which multivalent metals can catalyze hydrogen peroxide decomposition through chemical absorption of oxygen to convert to higher electronic states; and pH, in which in an alkaline solution hydrogen peroxide loses its activity more rapidly. While keeping the hydrogen peroxide solutions at a low pH through acid addition is one way of stabilizing the solution, the effect of low pH on the skin is not desirable, and can be even detrimental in extremely low levels.
Date recue / Date received 2021-11-02
Another attempt to enhance the efficacy of hydrogen peroxide disinfecting solutions is found in U.S. Patent No. 5264229 to Mannig et al. Mannig discloses a process for reducing the overall bacterial count and increasing the shelf life of the aqueous hydrogen peroxide solution by adding sulfo-based surfactants, such as, alkylaryl sulfonates, sulfates, sulfonates of oils and fatty acid, sulfate of alcohols and sulfosuccinates.
In U.S. Patent No. 7658953, a biocidal hydrogen peroxide composition is enhanced by the addition of a surfactant with the structure: R-0-(CH(Y)-CH2-0)n-CH2-COOH, wherein R is C6 to C12 alkyl, Y is H or CH3, and n is 3- 10. The addition of the surfactant was reported to achieve a Log 6 reduction of bacteria in a bacteria suspension within 1-minute following contact with the composition.
Several other patents and patent publications disclose the addition of anionic surfactants based on sulfonic acid to increase the kill rate of an aqueous hydrogen peroxide disinfecting solution: U.S. Patent No. 7354604, U.S. Publication Nos.: 2010/0330196, 2011/0262557, 2011/0129435, 2011/0182958, 2012/0230869, 2012/0177746, 2012/0164237, and European Publication No.: 2338343. The anionic surfactant is chosen from C8 to C16 alkyl aryl sulfonic acids, sulfonated C12 to C22 carboxylic acids, Ce to C22 alkyl diphenyl oxide sulfonic acids, C8 to C22 alkyl sulfonic acids, and Ce to C18 alkyl or alkenyl esters of sulfosuccinic acids.
However, the use of anionic sulfonic acid-based surfactants is less desirable in applications where disinfection, and not cleaning, is the primary function to be achieved.
Furthermore, hydrogen peroxide solutions suffer from loss of activity over time. As the physical chemistry of hydrogen peroxide suggests, and is confirmed through practical monitoring, hydrogen peroxide solutions tend to dissociate and release oxygen over time, converting to water and nascent active oxygen. High-strength hydrogen peroxide solutions can go through this dissociation process rapidly and, occasionally, violently. Low-strength hydrogen peroxide solutions dissociate more slowly but, nevertheless, lose their activity over a long storage period. The mechanisms through which this dissociation happens are categorized as metal catalyzed reactions, in which multivalent metals can catalyze hydrogen peroxide decomposition through chemical absorption of oxygen to convert to higher electronic states; and pH, in which in an alkaline solution hydrogen peroxide loses its activity more rapidly. While keeping the hydrogen peroxide solutions at a low pH through acid addition is one way of stabilizing the solution, the effect of low pH on the skin is not desirable, and can be even detrimental in extremely low levels.
Date recue / Date received 2021-11-02
8 Saponins are a large and structurally diverse group of bioactive natural products that are found primarily in plants, most commonly within the dicots. They are compounds constructed of a triterpene or steroid moiety (aglycon or sapogenin) and one or two glycoside moieties (monodesmosides or bidesmosides, respectively). The aglycon carbon skeleton may be saturated or unsaturated and/or contain a heteroatom, such as nitrogen. The glycoside moiety contains sugars, such as galactose, glucose, glucuronic acid, methylpentose, rhamnose and xylose.
It has now been found that saponins act as an effective additive to enhance and accelerate the biocidal functionality of hydrogen peroxide-containing solutions and thereby help alleviate a major disadvantage of hydrogen peroxide as a sanitizer.
As another benefit, saponins add natural-based foaming and detergency to hydrogen peroxide-containing disinfectants thereby eliminating the need for synthetic surfactants.
Thus, described herein is a disinfectant composition comprising a hydrogen peroxide source and a saponin source.
Any source of hydrogen peroxide is contemplated for use herein. Typically, however, the hydrogen peroxide source comprises hydrogen peroxide, sodium percarbonate, potassium percarbonate, sodium perborate, potassium perborate, hydrogen peroxide urea, hydrated forms thereof, or mixtures thereof. In aspects, the hydrogen peroxide source is an aqueous solution containing about 20% to about 50% by weight hydrogen peroxide dissolved in water. In other aspects, the hydrogen peroxide source is a solid formulation of sodium percarbonate.
As will be apparent to those skilled in the art, the amount of hydrogen peroxide used in the composition will vary depending on the application and whether the composition is a concentrate or a ready-to-use solution. The amount of the hydrogen peroxide in the concentrate is typically from about 1.0 to about 8.0 w/w % of the total formulation depending on storage stability, such as from about 1.0, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, or about 7.5 to about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, about 7.5, or about 8.0 w/w %. Typically, the concentrate contains from about 2 w/w % to about 7 w/w % of the hydrogen peroxide.
In contrast, the amount of hydrogen peroxide in the ready-to-use solution is a biocidal amount that can range from about 0.05 w/w % to about 5.0 w/w % of the total solution depending on application, such as from about 0.05, about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, or about 5.0 w/w %. Typically, the biocidal amount ranges Date recue / Date received 2021-11-02
It has now been found that saponins act as an effective additive to enhance and accelerate the biocidal functionality of hydrogen peroxide-containing solutions and thereby help alleviate a major disadvantage of hydrogen peroxide as a sanitizer.
As another benefit, saponins add natural-based foaming and detergency to hydrogen peroxide-containing disinfectants thereby eliminating the need for synthetic surfactants.
Thus, described herein is a disinfectant composition comprising a hydrogen peroxide source and a saponin source.
Any source of hydrogen peroxide is contemplated for use herein. Typically, however, the hydrogen peroxide source comprises hydrogen peroxide, sodium percarbonate, potassium percarbonate, sodium perborate, potassium perborate, hydrogen peroxide urea, hydrated forms thereof, or mixtures thereof. In aspects, the hydrogen peroxide source is an aqueous solution containing about 20% to about 50% by weight hydrogen peroxide dissolved in water. In other aspects, the hydrogen peroxide source is a solid formulation of sodium percarbonate.
As will be apparent to those skilled in the art, the amount of hydrogen peroxide used in the composition will vary depending on the application and whether the composition is a concentrate or a ready-to-use solution. The amount of the hydrogen peroxide in the concentrate is typically from about 1.0 to about 8.0 w/w % of the total formulation depending on storage stability, such as from about 1.0, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, or about 7.5 to about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, about 7.5, or about 8.0 w/w %. Typically, the concentrate contains from about 2 w/w % to about 7 w/w % of the hydrogen peroxide.
In contrast, the amount of hydrogen peroxide in the ready-to-use solution is a biocidal amount that can range from about 0.05 w/w % to about 5.0 w/w % of the total solution depending on application, such as from about 0.05, about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, or about 5.0 w/w %. Typically, the biocidal amount ranges Date recue / Date received 2021-11-02
9 from about 0.05 w/w % to about 2.0 w/w %. Typically, the ready-to-use solution contains from 0.1 to 1.5 w/w % of the hydrogen peroxide.
Saponin sources for use herein are diverse and the origin and extraction process of the saponin ingredient is not limiting. Typically, the saponin material is an extract of Camellia sinensis, soapwort (Saponaria officinalist), soapberry (Sapindus species), soapbark (Quillaja saponaria), Camellia oleifera, Sapindus mukorossi, sugar beet root saponins, or a mixture thereof.
The saponin material obtained from a plant source, e.g., Camellia oleifera, and/or Sapindus mukorossi, may be extracted as known in the art or as explained below as a reference only. The extraction process as presented for reference herein typically comprises treating the plant source in a water/alcohol solution under conditions permitting extraction of the saponin material into the solution. The extracted saponin containing material may subsequently be purified by any means known in the art, including filtration, centrifugation, re-crystallization, distillation, adsorption, chromatographic methods, fractionation, etc.
The plant source may or may not be first dried and ground prior to being treated in the water/alcohol solution.
As an example, the saponin material can be extracted from a plant source following a method comprised of:
1. treating the plant source in a 40:60 to 60:40 water: alcohol solution for a period of time and under conditions permitting extraction of the saponin material from said plant source into said solution;
2. optionally, evaporating the saponin-containing solution to obtain a saponin-containing solid material; and 3. optionally, purifying said saponin-containing solid material.
In some aspects, the plant source is Sapindus mukorossi and the saponin material is extracted from the nutshell. In other aspects, the plant source is Camellia oleifera and in some embodiments the saponin material is extracted from the defatted seed meal of Camellia oleifera.
In other aspects, the saponin source is Yocca saponin powder.
In typical aspects, the amount of the saponin material of the total weight of the solid materials in the extract composition is in the range of 0.01-99 wt %.
As will be apparent to those skilled in the art, the amount of saponin used in the composition will vary depending on the application and whether the composition is a concentrate or a ready-to-use solution. The amount of the saponin material in the concentrated product is typically from about 1 w/w % to about 10 w/w % of the total formulation, such as from about 1.0, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, Date recue / Date received 2021-11-02
Saponin sources for use herein are diverse and the origin and extraction process of the saponin ingredient is not limiting. Typically, the saponin material is an extract of Camellia sinensis, soapwort (Saponaria officinalist), soapberry (Sapindus species), soapbark (Quillaja saponaria), Camellia oleifera, Sapindus mukorossi, sugar beet root saponins, or a mixture thereof.
The saponin material obtained from a plant source, e.g., Camellia oleifera, and/or Sapindus mukorossi, may be extracted as known in the art or as explained below as a reference only. The extraction process as presented for reference herein typically comprises treating the plant source in a water/alcohol solution under conditions permitting extraction of the saponin material into the solution. The extracted saponin containing material may subsequently be purified by any means known in the art, including filtration, centrifugation, re-crystallization, distillation, adsorption, chromatographic methods, fractionation, etc.
The plant source may or may not be first dried and ground prior to being treated in the water/alcohol solution.
As an example, the saponin material can be extracted from a plant source following a method comprised of:
1. treating the plant source in a 40:60 to 60:40 water: alcohol solution for a period of time and under conditions permitting extraction of the saponin material from said plant source into said solution;
2. optionally, evaporating the saponin-containing solution to obtain a saponin-containing solid material; and 3. optionally, purifying said saponin-containing solid material.
In some aspects, the plant source is Sapindus mukorossi and the saponin material is extracted from the nutshell. In other aspects, the plant source is Camellia oleifera and in some embodiments the saponin material is extracted from the defatted seed meal of Camellia oleifera.
In other aspects, the saponin source is Yocca saponin powder.
In typical aspects, the amount of the saponin material of the total weight of the solid materials in the extract composition is in the range of 0.01-99 wt %.
As will be apparent to those skilled in the art, the amount of saponin used in the composition will vary depending on the application and whether the composition is a concentrate or a ready-to-use solution. The amount of the saponin material in the concentrated product is typically from about 1 w/w % to about 10 w/w % of the total formulation, such as from about 1.0, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, Date recue / Date received 2021-11-02
10 about 5.5, about 6.0, about 6.5, about 7.0, about 7.5, about 8.0, about 8.5, about 9.0, or about 9.5 to about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, about 7.5, about 8.0, about 8.5, about 9.0, about 9.5, or about 10.0 w/w %. Typically, the concentrate contains from 1 w/w % to 5 w/w % of the saponin extract.
The amount of saponin extract in the ready-to-use solution is from about 0.05 w/w % to about 5 w/w % of the total solution, such as from about 0.05, about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, or about 5.0 w/w %.
Typically, the ready-to-use solution contains from about 0.5 w/w % to about 3 w/w % of the saponin extract.
Typically, the composition further comprises a solvent, particularly in the case of the ready-to-use composition. Typically, the solvent is an aqueous solvent, such as water, typically distilled water, and/or a water-miscible organic solvent, which is typically natural. Water-miscible organic solvents for use herein include, for example: Bio-based alcoholic solvents, such as ethanol, propanol, and butanol, with bio-based ethanol being the typical organic solvent. When the water-miscible organic solvent is used with water, it can be diluted in a range with water from about 0.1% to about 30% by weight of water present in the ready-to-use solution, such as from about 0.1, about 0.5, about 1, about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, about 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, about 25, about 26, about 27, about 28, or about 29 to about 0.5, about 1, about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, about 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, about 25, about 26, about 27, about 28, about 29 or about 30%.
In typical aspects, the composition described herein comprises a stabilizer.
Typically, the stabilizer comprises a metal chelator that is typically of natural origin.
Some amino acids as well as some carboxylic acids have been found to be effective metal chelators in the compositions described herein. Metal chelating amino acids and amino acid peptides generally include, but are not limited to, glutamic acid, histidine, glycine, and lysine. Carboxylic acids with chelation properties might be used alone or in combination with the above-mentioned amino acids for metal chelation. These carboxylic acids include, but are not limited to, acetic acid, gluconic acid, and citric acid.
The concentrated product prepared according to this application may contain from about 0.1% to about 5% of the metal chelator of choice, such as from about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 1.5, about 2.0, about 2.5, about Date recue / Date received 2021-11-02
The amount of saponin extract in the ready-to-use solution is from about 0.05 w/w % to about 5 w/w % of the total solution, such as from about 0.05, about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, or about 5.0 w/w %.
Typically, the ready-to-use solution contains from about 0.5 w/w % to about 3 w/w % of the saponin extract.
Typically, the composition further comprises a solvent, particularly in the case of the ready-to-use composition. Typically, the solvent is an aqueous solvent, such as water, typically distilled water, and/or a water-miscible organic solvent, which is typically natural. Water-miscible organic solvents for use herein include, for example: Bio-based alcoholic solvents, such as ethanol, propanol, and butanol, with bio-based ethanol being the typical organic solvent. When the water-miscible organic solvent is used with water, it can be diluted in a range with water from about 0.1% to about 30% by weight of water present in the ready-to-use solution, such as from about 0.1, about 0.5, about 1, about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, about 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, about 25, about 26, about 27, about 28, or about 29 to about 0.5, about 1, about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, about 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, about 25, about 26, about 27, about 28, about 29 or about 30%.
In typical aspects, the composition described herein comprises a stabilizer.
Typically, the stabilizer comprises a metal chelator that is typically of natural origin.
Some amino acids as well as some carboxylic acids have been found to be effective metal chelators in the compositions described herein. Metal chelating amino acids and amino acid peptides generally include, but are not limited to, glutamic acid, histidine, glycine, and lysine. Carboxylic acids with chelation properties might be used alone or in combination with the above-mentioned amino acids for metal chelation. These carboxylic acids include, but are not limited to, acetic acid, gluconic acid, and citric acid.
The concentrated product prepared according to this application may contain from about 0.1% to about 5% of the metal chelator of choice, such as from about 0.1, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, or about 4.5 to about 1.5, about 2.0, about 2.5, about Date recue / Date received 2021-11-02
11 3.0, about 3.5, about 4.0, about 4.5, or about 5.0 w/w %. The diluted, ready-to-use product may contain from 0.05 to as much as 1% of the metal chelator, such as from about 0.05, about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, or about 0.9 to about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, or about 1.0 w/w%.
In typical aspects, the composition is free of surfactants other than the saponin source.
In additional or alternative aspects, the composition is free of synthetic surfactants.
The composition typically has a pH of from about 3 to about 6, such as from about 4 to about 5, such as from about 3, about 4, or about 5 to about 4, about 5, or about 6.
The composition may be provided as a concentrate or a ready-to-use formulation.
Typically, the concentrate is a liquid or powder. The powder may be formulated as a tablet, a capsule, or granules, for example.
The composition typically disinfects a surface more quickly than a matched composition without a saponin source and/or stabilizer and is typically effective against bacteria, viruses, fungi, yeast, or combinations thereof. For example, the composition is in aspects effective against pathogens such as MRSA, E. coil, coronaviruses such as SARS-CoV-1, SARS-CoV-2, and MERS-CoV; influenza viruses such as Hi Ni, H5N1; Acinetobacter baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Candida albicans, or combinations thereof.
Also provided are products comprising the composition described herein. For example, a hand sanitizer comprising the composition is provided, as well as a spray, a powder, or a tablet.
In other aspects, the composition is, for example, in the form of a gel, cream, ointment, paste, lotion, or spreadable solid.
Also provided are methods of sanitizing or disinfecting a surface, wherein the methods comprises applying the composition described herein to the surface for a period of time, such as from about 1 second to about 30 minutes, such as from about 1 second, about 10 seconds, about 30 seconds, about 1 minute, about 2 minutes, about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, or about 25 minutes to about 10 seconds, about 30 seconds, about 1 minute, about 2 minutes, about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, about 25 minutes, or about 30 minutes Typically, the surface comprises skin, furniture, medical equipment, fabric, textiles, paper, kitchen surfaces, or combinations thereof.
The compositions may comprise additional agents and/or excipients as will be understood to a skilled person. For example, buffers such as EDTA may be included, pH
adjusting excipients or buffers such as sodium bicarbonate may be included, and/or fragrances such as essential oils may be included in the compositions described herein.
Date recue / Date received 2021-11-02
In typical aspects, the composition is free of surfactants other than the saponin source.
In additional or alternative aspects, the composition is free of synthetic surfactants.
The composition typically has a pH of from about 3 to about 6, such as from about 4 to about 5, such as from about 3, about 4, or about 5 to about 4, about 5, or about 6.
The composition may be provided as a concentrate or a ready-to-use formulation.
Typically, the concentrate is a liquid or powder. The powder may be formulated as a tablet, a capsule, or granules, for example.
The composition typically disinfects a surface more quickly than a matched composition without a saponin source and/or stabilizer and is typically effective against bacteria, viruses, fungi, yeast, or combinations thereof. For example, the composition is in aspects effective against pathogens such as MRSA, E. coil, coronaviruses such as SARS-CoV-1, SARS-CoV-2, and MERS-CoV; influenza viruses such as Hi Ni, H5N1; Acinetobacter baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Candida albicans, or combinations thereof.
Also provided are products comprising the composition described herein. For example, a hand sanitizer comprising the composition is provided, as well as a spray, a powder, or a tablet.
In other aspects, the composition is, for example, in the form of a gel, cream, ointment, paste, lotion, or spreadable solid.
Also provided are methods of sanitizing or disinfecting a surface, wherein the methods comprises applying the composition described herein to the surface for a period of time, such as from about 1 second to about 30 minutes, such as from about 1 second, about 10 seconds, about 30 seconds, about 1 minute, about 2 minutes, about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, or about 25 minutes to about 10 seconds, about 30 seconds, about 1 minute, about 2 minutes, about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, about 25 minutes, or about 30 minutes Typically, the surface comprises skin, furniture, medical equipment, fabric, textiles, paper, kitchen surfaces, or combinations thereof.
The compositions may comprise additional agents and/or excipients as will be understood to a skilled person. For example, buffers such as EDTA may be included, pH
adjusting excipients or buffers such as sodium bicarbonate may be included, and/or fragrances such as essential oils may be included in the compositions described herein.
Date recue / Date received 2021-11-02
12 The above disclosure generally describes the present invention. A more complete understanding can be obtained by reference to the following specific Examples.
These Examples are described solely for purposes of illustration and are not intended to limit the scope of the invention. Changes in form and substitution of equivalents are contemplated as circumstances may suggest or render expedient. Although specific terms have been employed herein, such terms are intended in a descriptive sense and not for purposes of limitation.
Examples Methods Stability of solutions:
A stock solution of 3% hydrogen peroxide was prepared from non-stabilized Fisher brand 30% solution of hydrogen peroxide and divided into six equal aliquots.
To one aliquot, the above stabilizer package was added at a concentration of 0.1% and 0.5% and saponin was added to another two at the same concentration. The test containers were sealed and kept at ambient temperature for a period of 60 days, after which the containers were opened and the contents were examined for hydrogen peroxide content (biocidal activity). Two methods were used for the determination of assay hydrogen peroxide, as more particularly described herein.
Disinfection efficacy:
Bioluminescence is a practical and simple method used to quickly assess the bio-contamination of surfaces. The method has been developed based on the biochemical adenosine triphosphate ("ATP"), which is the energy molecule of all the living organisms, luciferin/luciferase, and oxygen. The reaction results in a light-emitting decay which can be detected and related to the amount of ATP. ATP monitoring is used in food and beverage facilities to confirm that ATP presence is eliminated or minimized by effective sanitation procedures.
The luminometer (in conjunction with ATP swabs) uses bioluminescence to detect residual ATP as an indicator of surface cleanliness. The presence of ATP on a surface indicates incomplete cleaning and the presence of ATP-containing contamination including bacteria.
Because ATP is present in all organic matter, all foods contain ATP at varying levels.
Therefore, the surfaces to be evaluated had to be thoroughly cleaned and tested for contamination prior to commencing the test.
Test results are presented as Relative Light Units ("RLU"). RLU is the unit of measurement used in bioluminescence. When a test swab is activated, a bioluminescent reaction occurs, generating light output. Luminometers measure and quantify that light with an RLU output. Because manufacturers use different sensor technologies and algorithms for Date recue / Date received 2021-11-02
These Examples are described solely for purposes of illustration and are not intended to limit the scope of the invention. Changes in form and substitution of equivalents are contemplated as circumstances may suggest or render expedient. Although specific terms have been employed herein, such terms are intended in a descriptive sense and not for purposes of limitation.
Examples Methods Stability of solutions:
A stock solution of 3% hydrogen peroxide was prepared from non-stabilized Fisher brand 30% solution of hydrogen peroxide and divided into six equal aliquots.
To one aliquot, the above stabilizer package was added at a concentration of 0.1% and 0.5% and saponin was added to another two at the same concentration. The test containers were sealed and kept at ambient temperature for a period of 60 days, after which the containers were opened and the contents were examined for hydrogen peroxide content (biocidal activity). Two methods were used for the determination of assay hydrogen peroxide, as more particularly described herein.
Disinfection efficacy:
Bioluminescence is a practical and simple method used to quickly assess the bio-contamination of surfaces. The method has been developed based on the biochemical adenosine triphosphate ("ATP"), which is the energy molecule of all the living organisms, luciferin/luciferase, and oxygen. The reaction results in a light-emitting decay which can be detected and related to the amount of ATP. ATP monitoring is used in food and beverage facilities to confirm that ATP presence is eliminated or minimized by effective sanitation procedures.
The luminometer (in conjunction with ATP swabs) uses bioluminescence to detect residual ATP as an indicator of surface cleanliness. The presence of ATP on a surface indicates incomplete cleaning and the presence of ATP-containing contamination including bacteria.
Because ATP is present in all organic matter, all foods contain ATP at varying levels.
Therefore, the surfaces to be evaluated had to be thoroughly cleaned and tested for contamination prior to commencing the test.
Test results are presented as Relative Light Units ("RLU"). RLU is the unit of measurement used in bioluminescence. When a test swab is activated, a bioluminescent reaction occurs, generating light output. Luminometers measure and quantify that light with an RLU output. Because manufacturers use different sensor technologies and algorithms for Date recue / Date received 2021-11-02
13 adding up the photons, RLU measurements will vary from system to system.
However, because the ATP bioluminescence reaction is linear, the more ATP present means the more light will be present.
The relationship between the amount of ATP on the sample and the RLU result reading on the luminometer is directly proportional to the amount of ATP collected from the sample. A
high RLU reading indicates a large amount of ATP at the test location. This in turn indicates improper cleaning and the presence of contaminants.
Cleaning properly results in less ATP at the location. Less ATP results in less light output during the bioluminescent reaction and consequently, a lower RLU
reading.
Example 1 A granite floor tile was selected and thoroughly disinfected with hot water and a cocktail of disinfectants. It was then tested for ATP until the readings consistently indicated RLU of 0-2 which represented a surface free of ATP within the margins of error.
A sample of seemingly contaminated water was collected from a pond and left stagnant for solid settlement for 3 days.
The granite tile was covered with a paper towel and the water was added to the towel in a dropwise manner until it was completely soaked. After a few hours, soaking was repeated, and the specimen was left to dry overnight. The next morning, the towel was removed, and two equal surface areas were selected and tested for ATP, the results in RLU were as follows:
Area 1:1057 Area 2: 998 Two 50 ml aliquots were taken from a bottle of fresh 3% hydrogen peroxide solution. 0.5 grams of Yocca saponin extract together with 14.5m1 of boiled and cooled distilled water was added to one aliquot such that the active material in each aliquot remained practically at the same level. Two pieces of paper towels were cut to cover each test area and put on top of each area. Area 1 was soaked with 3m1 of hydrogen peroxide with no other additive while area 2 was soaked with 3m1 of saponin containing hydrogen peroxide. After 5 minutes, both papers were removed, and the areas were tested again for ATP with results as follows:
Area 1:82 Area 2: 22 Example 2 Another sample of water was collected from a different location and was poured on a washed and dried polyester fabric until the fabric was soaked and ambient-dried 2 times over a Date recue / Date received 2021-11-02
However, because the ATP bioluminescence reaction is linear, the more ATP present means the more light will be present.
The relationship between the amount of ATP on the sample and the RLU result reading on the luminometer is directly proportional to the amount of ATP collected from the sample. A
high RLU reading indicates a large amount of ATP at the test location. This in turn indicates improper cleaning and the presence of contaminants.
Cleaning properly results in less ATP at the location. Less ATP results in less light output during the bioluminescent reaction and consequently, a lower RLU
reading.
Example 1 A granite floor tile was selected and thoroughly disinfected with hot water and a cocktail of disinfectants. It was then tested for ATP until the readings consistently indicated RLU of 0-2 which represented a surface free of ATP within the margins of error.
A sample of seemingly contaminated water was collected from a pond and left stagnant for solid settlement for 3 days.
The granite tile was covered with a paper towel and the water was added to the towel in a dropwise manner until it was completely soaked. After a few hours, soaking was repeated, and the specimen was left to dry overnight. The next morning, the towel was removed, and two equal surface areas were selected and tested for ATP, the results in RLU were as follows:
Area 1:1057 Area 2: 998 Two 50 ml aliquots were taken from a bottle of fresh 3% hydrogen peroxide solution. 0.5 grams of Yocca saponin extract together with 14.5m1 of boiled and cooled distilled water was added to one aliquot such that the active material in each aliquot remained practically at the same level. Two pieces of paper towels were cut to cover each test area and put on top of each area. Area 1 was soaked with 3m1 of hydrogen peroxide with no other additive while area 2 was soaked with 3m1 of saponin containing hydrogen peroxide. After 5 minutes, both papers were removed, and the areas were tested again for ATP with results as follows:
Area 1:82 Area 2: 22 Example 2 Another sample of water was collected from a different location and was poured on a washed and dried polyester fabric until the fabric was soaked and ambient-dried 2 times over a Date recue / Date received 2021-11-02
14 24-hour period. Two equal and separate areas were selected and swabbed for ATP
with following RLU readings:
Area 1: 243 Area 2: 291 Area 1 was soaked in a dropwise manner with 5m1 of the saponin containing hydrogen peroxide solution and area 2 was treated equally with 5m1 of commercial 70%
lso-Propyl Alcohol. After 5 minutes, the two areas were swabbed again for ATP and the related RLU
results were record as:
Area 1: 7 Area 2: 22 The above disclosure generally describes the present invention. Although specific terms have been employed herein, such terms are intended in a descriptive sense and not for purposes of limitation.
All publications, patents and patent applications cited above are herein incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety.
Although preferred embodiments of the invention have been described herein in detail, it will be understood by those skilled in the art that variations may be made thereto without departing from the spirit of the invention or the scope of the appended claims.
Date recue / Date received 2021-11-02
with following RLU readings:
Area 1: 243 Area 2: 291 Area 1 was soaked in a dropwise manner with 5m1 of the saponin containing hydrogen peroxide solution and area 2 was treated equally with 5m1 of commercial 70%
lso-Propyl Alcohol. After 5 minutes, the two areas were swabbed again for ATP and the related RLU
results were record as:
Area 1: 7 Area 2: 22 The above disclosure generally describes the present invention. Although specific terms have been employed herein, such terms are intended in a descriptive sense and not for purposes of limitation.
All publications, patents and patent applications cited above are herein incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety.
Although preferred embodiments of the invention have been described herein in detail, it will be understood by those skilled in the art that variations may be made thereto without departing from the spirit of the invention or the scope of the appended claims.
Date recue / Date received 2021-11-02
Claims (35)
1. A disinfectant composition comprising a hydrogen peroxide source and a saponin source.
2. The composition of claim 1, wherein the hydrogen peroxide source comprises hydrogen peroxide, sodium percarbonate, potassium percarbonate, sodium perborate, potassium perborate, hydrogen peroxide urea, hydrated forms thereof, or mixtures thereof.
3. The composition of claim 1 or 2, wherein the saponin source comprises a plant extract.
4. The composition of claim 3, wherein the plant extract comprises an extract of Camellia sinensis, soapwort (Saponaria officinalis), soapberry (Sapindus species), soapbark (Quillaja saponaria), Camellia oleifera, Sapindus mukorossi, sugar beet root saponins, or a mixture thereof.
5. The composition of claim 4, wherein the saponin is extracted from a nutshell of Sapindus mukorossi.
6. The composition of claim 4, wherein the saponin is extracted from the defatted seed meal of Camellia oleifera.
7. The composition of claim 3, wherein the saponin source is Yocca saponin powder.
8. The composition of any one of claims 1 to 7, wherein the composition comprises from about 0.05% to about 8% by weight of the hydrogen peroxide source, such as from about 1% to about 8% by weight for a concentrated composition and from about 0.05% to about 5% by weight for a ready-to-use composition.
9. The composition of any one of claims 1 to 8, wherein the composition comprises from about 0.01% to about 99% by weight of the saponin source, such as from about 1% to about 10% by weight for a concentrated composition and from about 0.05% to about 3%
by weight for a ready-to-use composition.
by weight for a ready-to-use composition.
10. The composition of any one of claims 1 to 9, further comprising a solvent.
Date recue / Date received 2021-11-02
Date recue / Date received 2021-11-02
11. The composition of claim 10, wherein the solvent comprises an aqueous solvent.
12. The composition of claim 11, wherein the aqueous solvent comprises distilled water.
13. The composition of any one of claims 10 to 12, wherein the solvent comprises a water-miscible organic solvent.
14. The composition of claim 13, wherein the water-miscible organic solvent comprises ethanol, propanol, and/or butanol.
15. The composition of claim 13 or 14, wherein the water-miscible organic solvent is present in an amount of from about 0.1% to about 30% by weight of water present in a ready-to-use composition.
16. The composition of any one of claims 1 to 15, further comprising a stabilizer.
17. The composition of claim 16, wherein the stabilizer comprises a metal chelator.
18. The composition of claim 17, wherein the metal chelator comprises an amino acid and/or a carboxylic acid.
19. The composition of claim 18, wherein the amino acid comprises glutamic acid, histidine, glycine and/or lysine and wherein the carboxylic acid comprises acetic acid, gluconic acid, and/or citric acid.
20. The composition of any one of claims 16 to 19, wherein the stabilizer comprises glutamic acid and citric acid.
21. The composition of any one of claims 16 to 20, wherein the stabilizer is present in an amount of from about 0.05% to about 5% by weight such as from about 0.1% to about 5% by weight for a concentrated composition and from about 0.05% to about 1% by weight for a ready-to-use composition.
Date recue / Date received 2021-11-02
Date recue / Date received 2021-11-02
22. The composition of any one of claims 1 to 21, wherein the composition is free of surfactants other than the saponin source.
23. The composition of any one of claims 1 to 22, wherein the composition is free of synthetic surfactants.
24. The composition of any one of claims 1 to 23, wherein the composition has a pH of from about 3 to about 6, such as from about 4 to about 5.
25. The composition of any one of claims 1 to 24, wherein the composition is a concentrate.
26. The composition of claim 25, wherein the concentrate is in the form of a powder or tablet.
27. The composition of any one of claims 1 to 26, wherein the composition is ready-to-use.
28. The composition of any one of claims 1 to 27, wherein the composition disinfects a surface more quickly than a matched composition without a saponin source and/or stabilizer.
29. The composition of any one of claims 1 to 28, wherein the composition is effective against bacteria, viruses, fungi, yeast, or combinations thereof.
30. The composition of any one of claims 1 to 29, wherein the composition is effective against pathogens such as MRSA, E. coli, coronaviruses such as SARS-CoV-1, SARS-CoV-2, and MERS-CoV; influenza viruses such as H1N1, H5N1; Acinetobacter baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Candida albicans, or combinations thereof.
31. A hand sanitizer comprising the composition of any one of claims 1 to 30.
32. A spray comprising the composition of any one of claims 1 to 30.
33. A powder or tablet comprising the composition of any one of claims 1 to 30.
Date recue / Date received 2021-11-02
Date recue / Date received 2021-11-02
34. A method of sanitizing a surface, the method comprising applying the composition of any one of claims 1 to 30 to the surface.
35. The method of claim 34, wherein the surface comprises skin, furniture, medical equipment, fabric, textiles, paper, kitchen surfaces, or combinations thereof.
Date recue / Date received 2021-11-02
Date recue / Date received 2021-11-02
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3137442A CA3137442A1 (en) | 2021-11-02 | 2021-11-02 | Disinfecting composition and related methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3137442A CA3137442A1 (en) | 2021-11-02 | 2021-11-02 | Disinfecting composition and related methods |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3137442A1 true CA3137442A1 (en) | 2023-05-02 |
Family
ID=86184338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3137442A Pending CA3137442A1 (en) | 2021-11-02 | 2021-11-02 | Disinfecting composition and related methods |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA3137442A1 (en) |
-
2021
- 2021-11-02 CA CA3137442A patent/CA3137442A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6063495B2 (en) | Alpha-ketoperacids and methods for making and using the same | |
KR100317577B1 (en) | Composition and uses thereof | |
CA1081079A (en) | Stable aqueous peroxy-containing concentrate | |
US7465697B1 (en) | Essential oils based cleaning and disinfecting compositions | |
US9233180B2 (en) | Hydrogen peroxide disinfectant containing a cyclic carboxylic acid and/or aromatic alcohol | |
CA2545233A1 (en) | Disinfecting compositions and methods of making and using same | |
US20140179645A1 (en) | Antimicrobial compositions | |
US8147877B2 (en) | Essential oils based disinfecting compositions having tuberculocidal and fungicidal efficacies | |
JP2010504279A (en) | Methods and compositions for treating substances | |
WO2017112425A1 (en) | Compositions comprising an amide | |
JP2018537479A (en) | Composition comprising ester and / or acid | |
JP2013525378A (en) | Synergistic nonequilibrium aldehyde biocide | |
US11871749B2 (en) | Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof | |
EP0609106B1 (en) | A glutaraldehyde composition | |
CA3137442A1 (en) | Disinfecting composition and related methods | |
US20220132857A1 (en) | Disinfecting Composition and Related Methods | |
US5674829A (en) | Stable aqueous glutaraldehyde solutions containing sodium acetate and a nonionic detergent | |
RU2569761C2 (en) | Disinfectant composition | |
WO2023128947A1 (en) | Surface disinfectant | |
US20170266090A1 (en) | Antimicrobial compositions that are dermatologically non-drying | |
WO2023213521A1 (en) | Hard surface cleaning composition | |
JP2021178776A (en) | Anti-coronavirus (SARS-CoV-2) agent | |
SK500022011U1 (en) | Antiseptic formulation based on organic peroxides |